수의학 연구 장비 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Veterinary Research Equipment Market Summary

The global veterinary research equipment market size was estimated at USD 0.59 billion in 2024 and is projected to reach USD 1.11 billion by 2033, growing at a CAGR of 7.34% from 2025 to 2033. The market is advancing due to the rising prevalence of animal diseases, increasing investment in animal health and diagnostics, and growing demand for advanced research tools to support companion animal care and livestock productivity.

Additionally, technological advancements in imaging, molecular diagnostics, and lab automation are accelerating adoption across research institutions and veterinary clinics. The veterinary research equipment market is also boosted by the increasing utilization of advanced tools for veterinary research, drug development, biological agent production, and the development of treatments for various animal diseases and infections. The rising demand for precise diagnostics, molecular research, and controlled laboratory environments is fueling investments in instruments such as PCR systems, ELISA kits, imaging technologies, and automated laboratory equipment.

For example, data from Understanding Animal Research (UAR) in September 2024 reported that ten major organizations in Great Britain conducted 54% of all animal research in 2023, amounting to over 1.4 million procedures out of a total of 2.68 million. The majority of these studies (99%) involved mice, fish, and rats, highlighting the critical role of veterinary research equipment in supporting large-scale, high-throughput animal studies for scientific, pharmaceutical, and disease-prevention purposes.

Furthermore, partnerships with international research institutions can lead to knowledge transfer and technological advancements. For instance, the establishment of advanced veterinary research facilities aligns with Vision 2030, supporting innovation and sustainability in the animal healthcare sector.

Global Veterinary Research Equipment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary research equipment market report based on product, animal, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• In Vivo Research Equipment
• Molecular Biology & Genomics Equipment
• Diagnostic Lab Instruments
• Surgical & Preclinical Equipment
• Histopathology & Microscopy Equipment
• Others
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Small Animal
• Large Animal
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug Discovery & Preclinical Testing
• Vaccine Development & Immunology
• Disease Research
• Toxicology Studies
• Genomics & Molecular Research
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic & Educational Institutions
• Animal-Health Research Institutes
• Pharmaceutical & Biotechnology Companies
• Veterinary Diagnostic & Reference Laboratories
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom-Up Analysis
  • 1.7.3. Model 3 Volume-Pricing Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
  • 3.2.5. Technology Landscape
• 3.3. Pricing Model Analysis
• 3.4. Market Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Research Equipment Market: By Product Estimates & Trend Analysis

• 4.1. Veterinary Research Equipment Market, By Product: Segment Dashboard
• 4.2. Veterinary Research Equipment Market, By Product Movement Analysis
• 4.3. Veterinary Research Equipment Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. In Vivo Research Equipment
  • 4.4.1. In Vivo Research Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Molecular Biology & Genomics Equipment
  • 4.5.1. Molecular Biology & Genomics Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Diagnostic Lab Instruments
  • 4.6.1. Diagnostic Lab Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Surgical & Preclinical Equipment
  • 4.7.1. Surgical & Preclinical Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Histopathology & Microscopy Equipment
  • 4.8.1. Histopathology & Microscopy Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Research Equipment Market: By Animal Estimates & Trend Analysis

• 5.1. Veterinary Research Equipment Market, By Animal: Segment Dashboard
• 5.2. Veterinary Research Equipment Market, By Animal Movement Analysis
• 5.3. Veterinary Research Equipment Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 5.4. Small Animals
  • 5.4.1. Small Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Large Animals
  • 5.5.1. Large Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Research Equipment Market: By Application Estimates & Trend Analysis

• 6.1. Veterinary Research Equipment Market, By Application: Segment Dashboard
• 6.2. Veterinary Research Equipment Market, By Application Movement Analysis
• 6.3. Veterinary Research Equipment Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
• 6.4. Drug Discovery & Preclinical Testing
  • 6.4.1. Drug Discovery & Preclinical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Vaccine Development & Immunology
  • 6.5.1. Vaccine Development & Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Disease Research
  • 6.6.1. Disease Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Toxicology Studies
  • 6.7.1. Toxicology Studies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Genomics & Molecular Research
  • 6.8.1. Genomics & Molecular Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Research Equipment Market: By End Use Estimates & Trend Analysis

• 7.1. Veterinary Research Equipment Market, By End Use: Segment Dashboard
• 7.2. Veterinary Research Equipment Market, By End Use Movement Analysis
• 7.3. Veterinary Research Equipment Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 7.4. Academic & Educational Institutions
  • 7.4.1. Academic & Educational Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Animal-Health Research Institutes
  • 7.5.1. Animal-Health Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Pharmaceutical & Biotechnology Companies
  • 7.6.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Veterinary Diagnostic & Reference Laboratories
  • 7.7.1. Veterinary Diagnostic & Reference Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Research Equipment Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2024 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Middle East and Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. IDEXX Laboratories
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Bionote
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Agrivet Laboratories
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Miltenyi Biotec
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Bruker Corporation
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. PerkinElmer
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Thermo Fisher Scientific
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. InGeneron
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Esco Lifesciences
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. MRC Group
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. INFITEK INC.
    • 9.3.11.1. Participant's Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product Benchmarking
    • 9.3.11.4. Strategic Initiatives